Filter announcements
Loading...
Torrent Pharmaceuticals Ltd is one of the leading Indian Pharmaceutical Company engaged in research, development, manufacturing and marketing of generic pharmaceutical formulations.
Torrent Pharma submitted its FY25-26 BRSR, showcasing strong ESG performance and improved resource efficiency. The company incurred over ` 48 crore in fines from NPPA and GST authorities for various issues. Operational advancements and local sourcing initiatives continue.
Torrent Pharmaceuticals has fully redeemed and repaid Commercial Papers totaling ₹200 Cr. This action reduces the company's short-term financial obligations, positively impacting its balance sheet and financial health.
Torrent Pharmaceuticals fully repaid and redeemed Commercial Papers totaling ₹ 200 Cr. This action settles a short-term debt, improving the company's balance sheet.
Torrent Pharma redeemed and repaid Non-Convertible Debentures (NCDs) totaling 142.84 Cr. This repayment, part of a 1,000 Cr issuance, reduces the company's overall debt obligations.
Torrent Pharmaceuticals Limited has informed the Exchange regarding ''.